This complimentary 5-module course is designed to provide foundational to advanced approaches to MASLD/MASH management. The online portion of this course includes 5 interactive modules covering topics from screening to risk stratification, to staging and monitoring, to evidence-based treatment strategies. This course has been designed to support learners in understanding the signs of and nuances in care of MASLD and MASH, and to provide a practical overview of current and emerging therapeutic options.
Additionally, there will be a live, case-based companion session at AACE’s 2026 Annual Meeting, where the faculty will review real MASLD and MASH cases to discuss nuances in team-based management.
The online portion of this course includes 5 modules:
Module 1: Understanding MASLD and MASH in Endocrinology
- Prevalence and risk factors
- Undiagnosed MASLD and MASH
Module 2: Overcoming Diagnostic Inertia
- Addressing common barriers to diagnosing MASLD and MASH in patients with multiple comorbidities
- The relationship between uncontrolled diabetes, hypercortisol states, and MASLD and MASH
- Recognizing MASLD and MASH as a cardio-kidney-metabolic condition requiring active treatment
Module 3: Screening, Staging, and Monitoring MASLD and MASH
- Screening high-risk populations
- Staging and monitoring strategies
Module 4: Evidence-Based Treatment of MASLD and MASH
- Current and emerging therapies
- The role of GLP-1 RAs
- Patient-centered treatment planning
Module 5: Holistic Management of the Cardio-Kidney-Metabolic Spectrum
- Treating overlapping conditions like obstructive sleep apnea, chronic pain, and metabolic syndrome
- The importance of a multidisciplinary approach to care.
Interested in participating in this course? Enroll today!
10/28/2025
10/28/2026
Upon completion of this program, learners will be able to:
- Identify high-risk patients with MASLD and MASH using evidence-based screening criteria to support early diagnosis and intervention.
- Assess the utility of staging and monitoring tools to evaluate disease progression and treatment response in patients with MASLD and MASH.
- Choose appropriate treatment strategies to optimize patient outcomes and align with current clinical practice guidelines.
- Differentiate between the roles of metabolic comorbidities in the progression of MASLD and MASH to develop more targeted treatment plans.
- Evaluate the impact of timely medical management and multidisciplinary care models on improving quality of life and reducing complications in patients with MASLD and MASH.
While this program has been designed primarily for U.S. based endocrinologists, other healthcare professionals, like nurses and physician assistants, working in endocrinology and caring for patients with MASLD and MASH may find this content useful.
SPEAKERS
FACULTY
Aman Rajpal, MD, Dipl. of ABOM
Diplomate, American Board of Clinical Lipidology
Assistant Clinical Professor, UCSF
Chief of Endocrinology, Department of Medicine
Alameda Health System
Javier Morales, MD, FACP, FACE
Vice President & Principal Clinical Trials Investigator
Advanced Internal Medicine Group
Associate Clinical Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Hofstra University
Physician Credit
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates enduring activity for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 2.5 contact hours.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
This program is funded by Novo Nordisk and Madrigal Pharmaceuticals.